CAS: 129688-50-2 - Minalrestat

Formule : C₁₉H₁₁BrF₂N₂O₄

InChI : InChI=1S/C19H11BrF2N2O4/c20-10-2-1-9(14(22)5-10)8-24-16(26)12-4-3-11(21)6-13(12)19(18(24)28)7-15(25)23-17(19)27/h1-6H,7-8H2,(H,23,25,27)

Code InChI : InChIKey=BMHZAHGTGIZZCT-UHFFFAOYSA-N

SMILES : O=C1NC(=O)C2(C(=O)N(C(=O)C3=CC=C(F)C=C32)CC4=CC=C(Br)C=C4F)C1

Synonymes :

• 2-(4-Bromo-2-fluorobenzyl)-6-fluorospiro(isoquinoline-4(1H),3'-pyrrolidine)-1,2',3,5'(2H)-tetrone
• 2-(4-bromo-2-fluorobenzyl)-6-fluoro-1H,2'H,5'H-spiro[isoquinoline-4,3'-pyrrolidine]-1,2',3,5'(2H)-tetrone
• 2-[(4-Bromo-2-fluorophenyl)methyl]-6-fluorospiro[isoquinoline-4(1H),3′-pyrrolidine]-1,2′,3,5′(2H)-tetrone
• Ari 509
• Minalrestat [USAN:INN]
• Spiro(isoquinoline-4(1H),3'-pyrrolidine)-1,2',3,5'(2H)-tetrone, 2-((4-bromo-2-fluorophenyl)-methyl)-6-fluoro-
• Spiro[isoquinoline-4(1H),3′-pyrrolidine]-1,2′,3,5′(2H)-tetrone, 2-[(4-bromo-2-fluorophenyl)methyl]-6-fluoro-
• Unii-G44Pe6Qb31
• Way-Ari-509
• Minalrestat

Minalrestat

CAS : 129688-50-2

Minalrestat(ARI-509) is an orally active and potent aldose reductase inhibitor for the study of impaired …

• Formule : C₁₉H₁₁BrF₂N₂O₄
• Degré de pureté : 100% - 98.79%
• Couleur et forme : Solid
• Masse moléculaire : 449.2

Minalrestat

CAS : 129688-50-2

Minalrestat is a drug that has been approved for use in humans to treat type …

• Formule : C₁₉H₁₁BrF₂N₂O₄
• Degré de pureté : Min. 95%
• Masse moléculaire : 449.2 g/mol